Stay updated with breaking news from Reneuron Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The global stem cell therapy market size is estimated to grow by USD 11.65 billion from 2023-2027, according to Technavio. The market is...
The industry is predicted to experience a notable expansion with a predicted global diagnostic exosome biomarkers market demand of US$ 196.8 million by 2023. The diagnostic exosome biomarkers sales are anticipated to thrive at a healthy CAGR of 16.3% between 2023 and 2033. A valuation of US$ 888.5 million is predict...
ReNeuron Group plc (LON:RENE – Get Free Report) shares were up 11.4% on Thursday . The stock traded as high as GBX 4.15 ($0.05) and last traded at GBX 3.90 ($0.05). Approximately 2,480,290 shares were traded during trading, an increase of 130% from the average daily volume of 1,076,155 shares. The stock had previously closed […]
ReNeuron Group plc (LON:RENE – Get Free Report)’s share price hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as GBX 4.25 ($0.05) and last traded at GBX 4 ($0.05), with a volume of 101044 shares trading hands. The stock had previously closed at GBX 4.75 ($0.06). ReNeuron […]
ReNeuron Group plc (LON:RENE – Get Free Report)’s stock price hit a new 52-week low during trading on Wednesday . The stock traded as low as GBX 4.25 ($0.05) and last traded at GBX 4 ($0.05), with a volume of 101044 shares changing hands. The stock had previously closed at GBX 4.75 ($0.06). ReNeuron Group […]